| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Jun―13 |
Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review |
Sudip Bhattacharya, Soumi Kundu |
| 2 |
[GO] |
2024―Jul―30 |
Chronic urticaria: not only after COVID-19 vaccination |
Mona-Rita Yacoub, Arianna Ferlito, Eustachio Nettis |
| 3 |
[GO] |
2023―Nov―14 |
SARS-CoV-2 vaccination in primary antibody deficiencies: an overview on efficacy, immunogenicity, durability of immune response and safety |
Gabriella Cusa, Germano Sardella, Giulia Garzi, Davide Firinu, Cinzia Milito |
| 4 |
[GO] |
2023―Feb―08 |
Coronavirus disease 2019 and severe asthma |
Alida Benfante, Giuseppe Pirrello, Francesca Sala, Gabriele Seminara, Nicola Scichilone |
| 5 |
[GO] |
2023―Feb―02 |
COVID-19 and autoimmune diseases: is there a connection? |
Martina Votto, Riccardo Castagnoli, Gian Luigi Marseglia, Amelia Licari, Ilaria Brambilla |
| 6 |
[GO] |
2022―Sep―27 |
Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding |
Clare Morgan, Stephen Jolles, Mark J. Ponsford, Kimberly Evans, Emily Carne |
| 7 |
[GO] |
2022―Feb―07 |
Coronavirus disease 2019 and pediatric asthma |
Elissa M. Abrams |
| 8 |
[GO] |
2021―Okt―01 |
COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency |
Mark J. Ponsford, Benjamin M.J. Shillitoe, Ian R. Humphreys, Andrew R. Gennery, Stephen Jolles |
| 9 |
[GO] |
2021―Sep―28 |
COVID-19 in complex common variable immunodeficiency patients affected by lung diseases |
Cinzia Milito, Valentina Soccodato, Stefania Auria, Federica Pulvirenti, Isabella Quinti |
| 10 |
[GO] |
2021―Sep―27 |
Antibody therapy for COVID-19 |
Lennart Hammarström, Harold Marcotte, Antonio Piralla, Fausto Baldanti, Qiang Pan-Hammarström |
| 11 |
[GO] |
2021―Sep―21 |
Biological therapies, asthma and coronavirus disease 2019 |
Amélia Ribeiro, Rita Aguiar, Mário Morais-Almeida |
| 12 |
[GO] |
2021―Sep―08 |
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection |
Stuart Tangye, Giorgia Bucciol, Isabelle Meyts |
| 13 |
[GO] |
2021―Aug―02 |
Anaphylaxis and Coronavirus Disease 2019 vaccine |
Luciana Kase Tanno, Mariana Castells, Marco Caminati, Gianenrico Senna, Pascal Demoly |
| 14 |
[GO] |
2021―Jul―16 |
The effects of the COVID-19 pandemic on the treatment of allergic eye diseases |
Andrea Leonardi, Elena Salami, Oren Mark Feuerman, Fabiano Cavarzeran |
| 15 |
[GO] |
2021―Mrz―26 |
The microbiome in atopic patients and potential modifications in the context of the severe acute respiratory syndrome coronavirus 2 pandemic |
Eun Lee, Soo-Jong Hong |
| 16 |
[GO] |
2021―Feb―21 |
Olfactory and taste dysfunctions in COVID-19 |
Philip W. Rouadi, Samar A. Idriss, Jean Bousquet |
| 17 |
[GO] |
2021―Feb―06 |
Paediatric allergy practice in the era of coronavirus disease 2019 |
S. Shahzad Mustafa, Marcus S. Shaker, Daniel Munblit, Matthew Greenhawt |
| 18 |
[GO] |
2021―Feb―06 |
Is asthma a risk factor for coronavirus disease-2019 worse outcomes? The answer is no, but … |
Priscila A. Franco, Sergio Jezler, Alvaro A. Cruz |
| 19 |
[GO] |
2021―Jan―20 |
Atopic endotypes as a modulating factor for SARS-CoV-2 infection |
Kyle S. Huntley, Lauren Fine, Jonathan A. Bernstein |
| 20 |
[GO] |
2021―Jan―05 |
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019 |
Dylan T. Timberlake, Kasey Strothman, Mitchell H. Grayson |
| 21 |
[GO] |
2020―Dez―23 |
Profiling severe acute respiratory syndrome coronavirus 2 and its relevance to otolaryngologic examinations during the coronavirus disease 2019 pandemic |
Catherine P.L. Chan, Jason Y.K. Chan |
| 22 |
[GO] |
2020―Nov―17 |
Coronavirus disease 2019 and asthma, allergic rhinitis |
Mako Wakabayashi, Ruby Pawankar, Hidehiko Narazaki, Takahiro Ueda, Toshikazu Itabashi |
| 23 |
[GO] |
2020―Nov―09 |
Inflammatory endotypes of CRSwNP and responses to COVID-19 |
Ming Wang, Chengshuo Wang, Luo Zhang |
| 24 |
[GO] |
2020―Aug―02 |
Reconsidering anaphylaxis at the time of COVID-19 pandemic |
Gianenrico Senna, Marco Caminati, Mariana Castells |
